A New Patient Reported Outcome Instrument to Assess Symptom Experience in Women With Vulvar Neoplasms (WOMAN-PRO) (WOMAN-PRO)

Study Description

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Brief Summary:

Post-surgery complications in women with vulvar neoplasms (vulvar intraepithelial neoplasia and vulvar cancer) are still high and an instrument assessing patients self-reported post-vulval surgery symptom experiences is missing. The study aims to develop and validate a postoperative instrument to assess symptom experiences in women with vulvar neoplasms. In this mixed-method project 20 patients were interviewed, a WOMAN-PRO instrument was developed and content validity was tested by 6 experts and 10 patients. The instrument's psychometric properties and the prevalence of symptoms will be examined in a cross-sectional study in the University Hospitals Munich, Freiburg, Berlin, Düsseldorf, Zurich, Basel, Berne, and the Cantonal Hospital St. Gallen (N=150). The goal of this project is that symptom assessment becomes a standard component of clinical practice (to promote the early detection and treatment of symptoms) and research.

Condition or disease
Women With Vulvar Intraephitelial Neoplasia or Vulvar Cancer

Study Design

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type :	Observational
Estimated Enrollment :	150 participants
Official Title:	Creating and Validating a Patient-reported Outcome Instrument to Assess Symptom Experience Related to Surgical Wounds in Women With Vulvar Neoplasms - A Mixed Methods Study
Study Start Date :	January 2009
Estimated Primary Completion Date :	December 2011
Estimated Study Completion Date :	December 2011

Groups and Cohorts

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
post-surgery symptom experience; women with vulvar intraephitelial neoplasia or vulvar cancer

Outcome Measures

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Ages Eligible for Study:	18 Years and older (Adult, Senior)
Sexes Eligible for Study:	Female
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

women with vulvar intraephitelial neoplasia or vulvar cancer following vulvar surgery

Criteria

Inclusion Criteria:

• above 18 years old
• able to read and write German
• diagnosed with vulvar neoplasms
• treated with vulval surgery during the prior six month

Exclusion Criteria:

• cognitive impaired
• concurrently under psychiatric treatment or terminally ill

Contacts and Locations

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Contacts

Contact: Rebecca Spirig, Prof. PhD, RN		Rebecca.Spirig@usz.ch
Contact: Beate Senn, MSc, RN		Beate.Senn@unibas.ch

Locations

Germany
University Hospital Berlin	Recruiting
Berlin, Germany
University Hospital Dusseldorf	Recruiting
Dusseldorf, Germany
University Hospital Freiburg	Recruiting
Freiburg, Germany
University Hospital Munich	Recruiting
Munich, Germany
Switzerland
University Hospital Basel	Not yet recruiting
Basel, Switzerland
University Hospital Berne	Recruiting
Berne, Switzerland
Cantonal Hospital St. Gallen	Recruiting
St. Gallen, Switzerland
University Hospital Zurich	Recruiting
Zurich, Switzerland

Sponsors and Collaborators

University of Basel

University Hospital Inselspital, Berne

Foundation Cancer Research Switzerland

More Information

Go to 

Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Publications of Results:

Senn B, Mueller MD, Cignacco EL, Eicher M. Period prevalence and risk factors for postoperative short-term wound complications in vulvar cancer: a cross-sectional study. Int J Gynecol Cancer. 2010 May;20(4):646-54. doi: 10.1111/IGC.0b013e3181d92723.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Senn B, Eicher M, Mueller MD, Hornung R, Fink D, Baessler K, Hampl M, Denhaerynck K, Spirig R, Engberg S. A patient-reported outcome measure to identify occurrence and distress of post-surgery symptoms of WOMen with vulvAr Neoplasia (WOMAN-PRO) - a cross sectional study. Gynecol Oncol. 2013 Apr;129(1):234-40. doi: 10.1016/j.ygyno.2012.12.038. Epub 2013 Jan 3.

Responsible Party:	Prof. Dr. Rebecca Spirig, Institute of Nursing Science, University of Basel
ClinicalTrials.gov Identifier:	NCT01300663 History of Changes
Other Study ID Numbers:	412-09; KFS 02456-08-200 ( Other Grant/Funding Number: Foundation Cancer Research Switzerland, KFS 02456-08-200 )
First Posted:	February 23, 2011
Last Update Posted:	February 23, 2011
Last Verified:	February 2011

Additional relevant MeSH terms:

Neoplasms; Vulvar Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms	Neoplasms by Site; Vulvar Diseases; Genital Diseases, Female